fig1
![Tumor-associated antigen targets for novel immune-based strategies in prostate cancer](https://image.oaes.cc/ddbf224c-eb98-498b-adec-6fcc9cda96f5/jtgg8046.fig.1.jpg)
Figure 1. Schematic demonstrating the mechanism of action of BiTE & CAR-T. T-cell redirecting therapies targeting tumor-associated antigen of interest. mAB: Monoclonal antibody; scFv: single-chain variable fragment; TAA: tumor-associated antigen.